TY - JOUR
T1 - A Fuzzy System Classification Approach for QSAR Modeling of αAmylase and α-Glucosidase Inhibitors
AU - Diéguez-Santana, Karel
AU - Puris, Amilkar
AU - Rivera-Borroto, Oscar M.
AU - Casanola-Martin, Gerardo M.
AU - Rasulev, Bakhtiyor
AU - González-Díaz, Humberto
N1 - Publisher Copyright:
© 2022 Bentham Science Publishers.
PY - 2022/12
Y1 - 2022/12
N2 - Introduction: This report proposes the application of a new Machine Learning algorithm called Fuzzy Unordered Rules Induction Algorithm (FURIA)-C in the classification of druglike compounds with antidiabetic inhibitory ability toward the main two pharmacological targets: α-amylase and α-glucosidase. Methods: The two obtained QSAR models were tested for classification capability, achieving satisfactory accuracy scores of 94.5% and 96.5%, respectively. Another important outcome was to achieve various α-amylase and α-glucosidase fuzzy rules with high Certainty Factor values. Fuzzyrules derived from the training series and active classification rules were interpreted. An important external validation step, comparing our method with those previously reported, was also included. Results: The Holm’s test comparison showed significant differences (p-value<0.05) between FURIA-C, Linear Discriminating Analysis (LDA), and Bayesian Networks, the former beating the two latter according to the relative ranking score of the Holm’s test. Conclusion: From these results, the FURIA-C algorithm could be used as a cutting-edge technique to predict (classify or screen) the α-amylase and α-glucosidase inhibitory activity of new compounds and hence speed up the discovery of new potent multi-target antidiabetic agents.
AB - Introduction: This report proposes the application of a new Machine Learning algorithm called Fuzzy Unordered Rules Induction Algorithm (FURIA)-C in the classification of druglike compounds with antidiabetic inhibitory ability toward the main two pharmacological targets: α-amylase and α-glucosidase. Methods: The two obtained QSAR models were tested for classification capability, achieving satisfactory accuracy scores of 94.5% and 96.5%, respectively. Another important outcome was to achieve various α-amylase and α-glucosidase fuzzy rules with high Certainty Factor values. Fuzzyrules derived from the training series and active classification rules were interpreted. An important external validation step, comparing our method with those previously reported, was also included. Results: The Holm’s test comparison showed significant differences (p-value<0.05) between FURIA-C, Linear Discriminating Analysis (LDA), and Bayesian Networks, the former beating the two latter according to the relative ranking score of the Holm’s test. Conclusion: From these results, the FURIA-C algorithm could be used as a cutting-edge technique to predict (classify or screen) the α-amylase and α-glucosidase inhibitory activity of new compounds and hence speed up the discovery of new potent multi-target antidiabetic agents.
KW - Anti-diabetic agents
KW - FURIA-C
KW - induction rule
KW - LDA
KW - machine-learning techniques
KW - QSAR
UR - http://www.scopus.com/inward/record.url?scp=85144008731&partnerID=8YFLogxK
U2 - 10.2174/1573409918666220929124820
DO - 10.2174/1573409918666220929124820
M3 - Artículo
C2 - 36177632
AN - SCOPUS:85144008731
SN - 1573-4099
VL - 18
SP - 469
EP - 479
JO - Current Computer-Aided Drug Design
JF - Current Computer-Aided Drug Design
IS - 7
ER -